<DOC>
	<DOC>NCT02035293</DOC>
	<brief_summary>A standardized diagnostic strategy of pulmonary embolism will be applied to eligible patients, incorporating a clinical probability score (revised Geneva score), plasma D-dimer assay and if necessary, a multidetector-row CT angiography thoracic and venous ultrasound of the lower limbs. All the patient with a pulmonary embolism diagnosed or not, will be followed for 3 months.</brief_summary>
	<brief_title>Frequency of Diagnostic Symptomatic Pulmonary Embolism's in Patients Hospitalized for Clinical Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<criteria>Patients hospitalized for a COPD exacerbation COPD previously diagnosed Allergy to iodinated contrast Creatinine clearance &lt; 30 mL / min Patient hospitalized for exacerbation of COPD for more than 48 hours Pneumothorax Exams impossible to be performed Pregnancy Life expectancy &lt; 3 months Patients already receiving anticoagulant therapy for another reason (mechanical valve, cardiac arrhythmia).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>COPD Exacerbation</keyword>
	<keyword>Pulmonary embolism</keyword>
	<keyword>Standardized and consensus diagnostic strategy</keyword>
</DOC>